CCL7 as a novel inflammatory mediator in cardiovascular disease, diabetes mellitus, and kidney disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2840
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
CCL7 as a novel inflammatory mediator in cardiovascular disease, diabetes mellitus, and kidney disease ; volume:21 ; number:1 ; day:15 ; month:9 ; year:2022 ; pages:1-8 ; date:12.2022
Cardiovascular diabetology ; 21, Heft 1 (15.9.2022), 1-8, 12.2022
- Creator
-
Chang, Ting-Ting
Chen, Ching
Chen, Jaw-Wen
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12933-022-01626-1
- URN
-
urn:nbn:de:101:1-2022120221413780126238
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chang, Ting-Ting
- Chen, Ching
- Chen, Jaw-Wen
- SpringerLink (Online service)
Other Objects (12)
FGF23 in Cardiovascular Disease: Innocent Bystander or Active Mediator?
Perspectives in Managing Kidney Disease and Atherosclerotic Cardiovascular Disease
Corrigendum: FGF23 in Cardiovascular Disease : Innocent Bystander or Active Mediator?
Cardiovascular risk due to diabetes mellitus in patients with chronic kidney disease — prospective data from the German Chronic Kidney Disease cohort
Cardiovascular complications of pediatric chronic kidney disease
Cardiovascular Calcification Heterogeneity in Chronic Kidney Disease
Cardiovascular Risk Prediction in Chronic Kidney Disease
Prognostic Cardiovascular Markers in Chronic Kidney Disease
Circulating Metabolites and Cardiovascular Disease in Asians with Chronic Kidney Disease
Cardiovascular Disease in Chronic Kidney Disease : Pathophysiological Insights and Therapeutic Options
Cardiovascular Calcification in Chronic Kidney Disease-Therapeutic Opportunities
Chronic kidney disease and associated cardiovascular disease: molecular alterations as biomarkers or regulators of disease
FGF23 in Cardiovascular Disease: Innocent Bystander or Active Mediator?
Perspectives in Managing Kidney Disease and Atherosclerotic Cardiovascular Disease
Corrigendum: FGF23 in Cardiovascular Disease : Innocent Bystander or Active Mediator?
Cardiovascular risk due to diabetes mellitus in patients with chronic kidney disease — prospective data from the German Chronic Kidney Disease cohort
Cardiovascular complications of pediatric chronic kidney disease
Cardiovascular Calcification Heterogeneity in Chronic Kidney Disease
Cardiovascular Risk Prediction in Chronic Kidney Disease
Prognostic Cardiovascular Markers in Chronic Kidney Disease
Circulating Metabolites and Cardiovascular Disease in Asians with Chronic Kidney Disease
Cardiovascular Disease in Chronic Kidney Disease : Pathophysiological Insights and Therapeutic Options
Cardiovascular Calcification in Chronic Kidney Disease-Therapeutic Opportunities
Chronic kidney disease and associated cardiovascular disease: molecular alterations as biomarkers or regulators of disease
FGF23 in Cardiovascular Disease: Innocent Bystander or Active Mediator?
Perspectives in Managing Kidney Disease and Atherosclerotic Cardiovascular Disease
Corrigendum: FGF23 in Cardiovascular Disease : Innocent Bystander or Active Mediator?
Cardiovascular risk due to diabetes mellitus in patients with chronic kidney disease — prospective data from the German Chronic Kidney Disease cohort
Cardiovascular complications of pediatric chronic kidney disease
Cardiovascular Calcification Heterogeneity in Chronic Kidney Disease
Cardiovascular Risk Prediction in Chronic Kidney Disease
Prognostic Cardiovascular Markers in Chronic Kidney Disease
Circulating Metabolites and Cardiovascular Disease in Asians with Chronic Kidney Disease
Cardiovascular Disease in Chronic Kidney Disease : Pathophysiological Insights and Therapeutic Options
Cardiovascular Calcification in Chronic Kidney Disease-Therapeutic Opportunities